Anna Health has filed a notice of an exempt offering of securities to raise $9,408,500.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Anna Health is raising up to $9,408,500.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.
About Anna Health
ANNA (Allied Network for Neurodevelopmental Advancement) is a leading organization dedicated to delivering compassionate and evidence-based care for children with autism. At ANNA, we recognize the uniqueness of each child with autism, tailoring our naturalistic approaches to meet their individual needs. Our focus is on creating interventions that are not only scientifically sound but also resonate with the true nature of the children we support. Our team comprises highly qualified professionals specializing in neurodevelopmental disorders, with a deep commitment to a multidisciplinary approach. This ensures a holistic and comprehensive treatment experience for each child. Our services are steeped in the latest scientific research, and we concentrate on enhancing key areas such as communication, social skills, and adaptive behaviors, while also addressing co-occurring conditions through our evidence-based practices. Our research division continually explores new methodologies and interventions, keeping our services at the cutting edge of neurodevelopmental care. We also engage in community outreach and advocacy, working to increase awareness about autism and to promote a culture of acceptance and understanding. Join ANNA, where compassion meets innovation, in our mission to create a world where individuals with autism can achieve their full potential, supported by a community that understands and values them.
To learn more about Anna Health, visit http://www.annaautismcare.com/
Anna Health Linkedin Page: https://www.linkedin.com/company/allied-network-for-neurodevelopmental-advancement/
Contact:
Aimun Malik, President
617-693-5767
https://www.linkedin.com/in/aimun-malik-8b557585/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.